As of 2026-09-11, the Intrinsic Value of Biophytis SA (ALBPS.PA) is -0.12 EUR. This ALBPS.PA valuation is based on the model Peter Lynch Fair Value. With the current market price of 0.07 EUR, the upside of Biophytis SA is -273.94%.
Based on its market price of 0.07 EUR and our intrinsic valuation, Biophytis SA (ALBPS.PA) is overvalued by 273.94%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -0.12 - -0.12 | -0.12 | -273.94% |
| P/E | (0.18) - (0.23) | (0.22) | -417.7% |
| DDM - Stable | (0.57) - 13.70 | 6.57 | 9597.7% |
| DDM - Multi | (0.73) - 13.73 | (1.56) | -2400.2% |
| Market Cap (mil) | 16.30 |
| Beta | 2.69 |
| Outstanding shares (mil) | 240.75 |
| Enterprise Value (mil) | 21.42 |
| Market risk premium | 5.82% |
| Cost of Equity | 5.92% |
| Cost of Debt | 5.00% |
| WACC | 5.26% |